May 2011 in “Journal of The American Academy of Dermatology” This research letter observed that patients with severe atopic dermatitis showed normal serum cortisol levels after hospitalization despite continued use of potent topical corticosteroids, though poor adherence may lead to overestimations of actual medication use.
July 2005 in “Journal of the American Academy of Dermatology” This letter critiques misconceptions about vegetarian diets in medical literature, emphasizing that properly planned vegetarian diets are nutritionally adequate and can offer significant health benefits.
November 2003 in “Hair transplant forum international” This letter discusses the complexities of a career in hair transplant surgery and reports no new research findings.
November 2002 in “International Society of Hair Restoration Surgery” This letter raises concerns about the International Alliance of Hair Restoration Surgeons and reports no new research findings.
May 1999 in “Hair transplant forum international” This letter challenges Dr. Rogers' comments about the British Association of Hair Restoration Surgeons, highlighting discrepancies between his statements and the facts; it provides no new research results.
March 1999 in “Hair transplant forum international” This letter shares personal insights and experiences from attending the World Hair Society meeting, providing no new research findings.
March 1999 in “Hair transplant forum international” This letter raises concerns about the use of hydrogen peroxide in hair restoration surgery but provides no new research findings.
January 1996 in “International Society of Hair Restoration Surgery” This letter from a practitioner about the 1995 Las Vegas hair restoration meeting expresses concerns but offers no new research findings or data.
November 1993 in “Hair transplant forum international” This letter raises concerns about the limited attention given to scalp reduction in hair restoration fields, with no new research data reported.
This letter humorously reflects on aging and disputes the notion of "Geezer syndrome" linked to the Great Depression, emphasizing resilience and growth in knowledge over time.
March 1983 in “Annals of Internal Medicine” This letter to the editor mentions reports of hair loss potentially related to 5-aminosalicylic acid enemas, but suggests it may be due to telogen effluvium from severe inflammatory bowel disease rather than a direct effect.
December 1977 in “Archives of Dermatology” This letter confirms that despite initial regrowth, a high recurrence rate of alopecia remains common, and only 28% of patients with alternate-day prednisone therapy saw lasting improvements.
December 1977 in “Archives of Dermatology” This letter discusses prior findings on prednisone for alopecia areata, agreeing that systemic steroids usually do not change the disease course but contesting that most patients have a poor prognosis.
This letter discusses the inadequacies of current fiber analysis methods and definitions, highlighting the significant differences between crude fiber and dietary fiber but does not provide new research findings.
July 1976 in “Archives of Dermatology” This letter argues that the lymphangitis reported from using cantharidin on warts is instead a case of aseptic necrosis common to other aggressive wart treatments.
This letter highlights that septicemia or bacteremic shock can be a complication of enemas in elderly men with prostate infections.
This letter challenges Dr. Dubois' statement that nearly all patients with Raynaud phenomenon will develop a systemic disorder, arguing that many experience it without progressing to serious disease.
July 1975 in “Archives of Dermatology” This letter to the editor describes two cases where stopping tetracycline treatment coincided with the disappearance of multiple flat warts on the face in young women.
September 1961 in “Archives of Dermatology” This letter contains an apology from the author to Dr. Malkinson for remarks that were unintentionally offensive, acknowledging Dr. Malkinson's superior understanding of the discussed problem.
February 2023 in “Clinical Toxicology” This letter to the editor raises concerns about minoxidil, an arterial vasodilator also used for androgenic alopecia, noting that overdose can cause severe side effects such as distributive shock, pulmonary edema, and myocardial ischemia.
April 2020 in “Journal of The American Academy of Dermatology” This letter highlights concerns about transient lymphadenopathy as a potential adverse effect of platelet-rich plasma combined with microneedling for alopecia, emphasizing the need to understand its underlying cause.
March 2020 in “Journal of Cosmetic Dermatology” This letter to the editor discusses patient perspectives on androgenetic alopecia treatment at a tertiary dermatology center in Singapore, though results or specific findings are not reported in the abstract.
37 citations
,
January 2019 in “Dermatologic Therapy” This article is a letter to the editor discussing the treatment of telogen effluvium using a dietary supplement, but it provides no new research results.
26 citations
,
September 2020 in “Journal of the European Academy of Dermatology and Venereology” This publication is a letter discussing the association between an androgen receptor genetic variant and COVID-19 disease severity in hospitalized male patients, but it reports no new research results.
15 citations
,
May 2017 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology” This article is a letter to the editor about high-dose pulsed corticosteroid therapy combined with methotrexate for severe childhood alopecia areata and provides no new clinical results.
11 citations
,
May 2017 in “Journal of The European Academy of Dermatology and Venereology” Results are not reported in this letter to the editor on the use of scalp threading with polydioxanone monofilament threads for hair restoration.
9 citations
,
December 2020 in “British Journal of Dermatology” This research letter reports that low-dose oral minoxidil improved hair density and length in children with loose anagen hair syndrome.
7 citations
,
April 2021 in “British Journal of Dermatology” In this research letter from the British Journal of Dermatology, the authors explore the use of topical tofacitinib to treat alopecia areata affecting facial hair, but specific results are not reported in the abstract.
7 citations
,
December 2013 in “The Journal of Dermatology” This article is a letter to the editor discussing hair graying and loss potentially induced by imatinib mesylate, but it does not provide new research results.
5 citations
,
August 2017 in “The Journal of Clinical Psychiatry” In this letter, excessive hair loss due to telogen effluvium was observed as a distressing side effect in the early months of valproate treatment, potentially linked to disruption in biotin metabolism, although the exact mechanism remains unclear.